SUMMARY In a case control study, prescription data were examined for the three months before the last menstrual period and for the first trimester ofpregnancy in (a) 115 mothers ofchildren with limb reduction defects, (b) 676 mothers of children with oral cleft, and (c) an equal number of control mothers ofnormal babies from the same doctor's practice for each case. In the limb reduction study, the study mothers were prescribed more drugs generally although this did not reach statistical significance, nor were there significant differences between study and control mothers for individual groups of drugs. In the oral cleft study, significantly more drugs were prescribed to study mothers in the three months before the last menstrual period, and a similar trend, which did not reach statistical significance, was observed in the first trimester. Anticonvulsant drugs were prescribed significantly more frequently to study mothers during the whole period of the study. A significant association was also demonstrated between oral contraceptives taken in the three months before the last menstrual period and oral cleft, but doubt must remain concerning this relationship; the risk is not well understood and is likely to be nonspecific. A number of other significant associations were identified, although their importance in practice is uncertain in view ofthe confounding factors that may affect a study of this kind.
Certain congenital malformations are known to be related to the use of drugs in early pregnancy, the best known examples being the limb reduction (and other) defects caused by thalidomide and the relation of oral clefts to anticonvulsants. ' However, the evidence for teratogenicity of other commonly used drugs, such as steroid hormones and antinauseants, is more controversial. '2 The present study, the fourth in a series carried out jointly by the Committee on Safety of Medicines (CSM) and the Office of Population Censuses and Surveys (OPCS), was therefore undertaken to see whether the use of drugs commonly prescribed around the time of conception, or in the first trimester, was associated with subsequent limb reduction defects or oral cleft in the babies. These are both congenital abnormalities known to be drug related in some instances and are readily diagnosed at birth. 14 
Subjects and methods
The selection of subjects and method of study were *Present address: 53 London. similar to those in previous investigations.6 13 The study population consisted of all infants born with oral cleft and/or major limb reduction defects during the 12 month period from 1 October 1983 and notified to the OPCS congenital malformation surveillance system. Each infant was matched with a control, the next normal infant born in the same general practice as the abnormal child within three months of the latter's birth. This design was chosen to minimise the effect of any change in prescribing habits by the family practitioner as a result of the birth of a malformed baby in the practice. The family practitioner in each case was identified with permission from the District Health Authorities and was visited by one of the CSM's part time medical officers who obtained from the written practice records the available details of the mother's personal and family history of congenital malformations (in first cousins or closer), her obstetric history, and the drugs prescribed during the three months before the last menstrual period (PLMP) and during the first trimester (FT) of the pregnancy resulting in the malformed child. The presence and nature ofthe malformation as notified were confirmed with the practitioner's records, and a control was selected and documented in the same way as for the study case. (table 2) .
There were significant differences between the study and control mothers with regard to age and social class distribution, the study group containing more very young (under 25) and older (35 and over) women (p < 0-01) and more from the manual class, as assessed by the general practitioner (p<0-01). There was no difference between the groups in previous live/ stillbirths, but previous miscarriages (including terminations) were significantly more common in the study group (141 study, 108 control mothers, p <0 01).
The malformed babies showed the expected excess of stillbirths, prematurity, and early deaths (183 study and 70 control babies). The sex and cleft distribution 
Discussion
Although we believe that the cases finally included in the limb reduction defect study were a representative sample of major limb reduction defects, the study lacked power because of the small numbers. Accordingly, the discussion here concentrates on the results of the oral cleft study. The study population was a representative sample of the abnormality with distribution of clefting, sex, and family history corresponding to that usually described.
The design of the study is, however, open to criticism. Inmaioa-was-obtaiellf mhe family practitioners' recQrls, and thus-noinformation was available on medicines bought 'over the counter' or any others prescribed elsewhere buat not communicated to the practitioner, nor is it known whether the medicines prescribed were all taken.
Nothis was known of maternal smoki ts, though orai clefting has sometimes been shown to h#ve a relation to smokinC16 17 However, the findings on anticonvulsants are in line with published work and suggest that some reliance can be placed on the methodology employed. There was a sigfi_ant degree of mismatch between the populations wih regard to maternal age, but this may have been a reflection of the known relation between increased maternal age and aLc Slefts, 18 19 and a greater incidence of congenital defects in women under 25 years has also been noted in a previous study.'3 The excess of prematurity, stillbirths, and early deaths in 6 the study infants agrees with the findings of other authors and is considered to be directly associated with the presence of malformations.2022 It should be noted that malformed terminations and miscarriages were not taken into account in this study and might have influenced the results.
The drugs that stood out above all others as a risk factor were the anticonvulsants, in particular pheqQbarbitone -and phenytoin. These drugs have repeatedly been shown to be teratogens associated with oral cleft and nail and digital reduction defects (which we did not consider here) and cardiac abnormalities.6 [22] [23] [24] Although phenobarbitone and phenytoin are particularly implicated, all anticonvulsants are under suspicion.4 [22] [23] [24] This was confirmed in the present study: the risk associated with the group as a whole was highly significant, but sufficient numbers for statistical analysis were available only for phenobarbitone and phenytoin. Anticonvulsants are known enzyme inducers25 making OC failure more likely, and they also have antifolate activity.3 There is therefore a need for more careful supervision of epileptics of childbearing age, with advice on contraception and, during pregnancy, possibly folate supplements.
No evidence was found in this study that an inherited tendency to delayed midline closure may predispose to oral clefting. Only two infants with neutral tube defects were reported in the study as a whole, and neither was born to a mother on anticonvulsants (or any other medication).
Steroid sex hormones, especially OCs, were also prescribed significantly more frequently to the study mothers in the PLMP period. This effect was also apparent in the periconceptual period but did not reach statistical significance, possibly due to the small numbers exposed. We examined the possibility that other drugs, such as anticonvulsants, might have contributed to the result, but this was not found to be the case; the pattern of additional drugs prescribed reflected the pattern of prescribing in the study as a whole, and no mother on OCs was taking anticonvulsants. Adjusting for age differences between cases and controls did not affect the result, and the distribution of clefts and of family histories followed that of the study population as a whole; no particular risk group was identified.
Nor Corticosteroids administered to animals in early pregnancy are known to produce oral glfts,36 37 but this has never been shown in man. The number of women exposed to betamethasone and beclomethasone in this study was very small, and the importance of the association with oral cleft must therefore remain doubtful.
In conclusion, the study shows generally increased prescribing in the periconceptua, perioQdin 
